Cardiovascular medication errors in children.

Area of Science:

• Pediatric pharmacology
• Medication safety
• Cardiovascular therapeutics

Background:

• Cardiovascular medications are essential for pediatric care.
• Medication errors pose a significant risk to patient safety, especially in vulnerable pediatric populations.
• Understanding error patterns is crucial for developing targeted interventions.

Purpose of the Study:

• To characterize pediatric cardiovascular medication errors.
• To identify patient demographics and specific medications associated with frequent or severe errors.
• To inform strategies for improving medication safety in children.

Main Methods:

• Analysis of 821 cardiovascular medication error reports from the USP MEDMARX database (2003-2004).
• Inclusion of patients under 18 years of age.
• Stratification of errors by harm score (near miss, no harm, harmful error) and drug class.

Main Results:

• Infants under 1 year old comprised 50% of reported errors.
• Improper dosing was the most common administration error.
• Diuretics were most frequently reported, while calcium channel blockers, phosphodiesterase inhibitors, antiarrhythmics, and digoxin showed higher proportions of harmful events.

Conclusions:

• Infants are a high-risk group for cardiovascular medication errors.
• Errors primarily occurred during medication administration, often due to dosing issues.
• While most errors caused no harm, continued monitoring and prevention efforts are necessary for pediatric cardiovascular medication safety.